Cargando…

Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study

BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rutao, Takahashi, Kuniaki, Garg, Scot, Thuijs, Daniel J. F. M., Kappetein, Arie Pieter, Mack, Michael J., Morice, Marie-Claude, Mohr, Friedrich-Wilhelm, Curzen, Nick, Davierwala, Piroze, Milojevic, Milan, van Geuns, Robert Jan, Head, Stuart J., Onuma, Yoshinobu, Holmes, David R., Serruys, Patrick W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484131/
https://www.ncbi.nlm.nih.gov/pubmed/33517534
http://dx.doi.org/10.1007/s00392-020-01802-x
_version_ 1784577253566316544
author Wang, Rutao
Takahashi, Kuniaki
Garg, Scot
Thuijs, Daniel J. F. M.
Kappetein, Arie Pieter
Mack, Michael J.
Morice, Marie-Claude
Mohr, Friedrich-Wilhelm
Curzen, Nick
Davierwala, Piroze
Milojevic, Milan
van Geuns, Robert Jan
Head, Stuart J.
Onuma, Yoshinobu
Holmes, David R.
Serruys, Patrick W.
author_facet Wang, Rutao
Takahashi, Kuniaki
Garg, Scot
Thuijs, Daniel J. F. M.
Kappetein, Arie Pieter
Mack, Michael J.
Morice, Marie-Claude
Mohr, Friedrich-Wilhelm
Curzen, Nick
Davierwala, Piroze
Milojevic, Milan
van Geuns, Robert Jan
Head, Stuart J.
Onuma, Yoshinobu
Holmes, David R.
Serruys, Patrick W.
author_sort Wang, Rutao
collection PubMed
description BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND RESULTS: The SYNTAXES study assessed the vital status out to 10 year of patients with three-vessel disease and/or left main coronary artery disease enrolled in the SYNTAX trial. The relative efficacy of PCI vs. CABG in terms of 10 year all-cause death was assessed according to prior CEVD. The primary endpoint was 10 year all-cause death. The status of prior CEVD was available in 1791 (99.5%) patients, of whom 253 patients had prior CEVD. Patients with prior CEVD were older and had more comorbidities (medically treated diabetes, insulin-dependent diabetes, metabolic syndrome, peripheral vascular disease, chronic obstructive pulmonary disease, impaired renal function, and congestive heart failure), compared with those without prior CEVD. Prior CEVD was an independent predictor of 10 year all-cause death (adjusted HR: 1.35; 95% CI: 1.04–1.73; p = 0.021). Patients with prior CEVD had a significantly higher risk of 10 year all-cause death (41.1 vs. 24.1%; HR: 1.92; 95% CI: 1.54–2.40; p < 0.001). The risk of 10 year all-cause death was similar between patients receiving PCI or CABG irrespective of the presence of prior CEVD (p(-interaction) = 0.624). CONCLUSION: Prior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD. Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-020-01802-x.
format Online
Article
Text
id pubmed-8484131
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84841312021-10-08 Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study Wang, Rutao Takahashi, Kuniaki Garg, Scot Thuijs, Daniel J. F. M. Kappetein, Arie Pieter Mack, Michael J. Morice, Marie-Claude Mohr, Friedrich-Wilhelm Curzen, Nick Davierwala, Piroze Milojevic, Milan van Geuns, Robert Jan Head, Stuart J. Onuma, Yoshinobu Holmes, David R. Serruys, Patrick W. Clin Res Cardiol Original Paper BACKGROUND: Coronary bypass artery grafting (CABG) has a higher procedural risk of stroke than percutaneous coronary intervention (PCI), but may offer better long-term survival. The optimal revascularization strategy for patients with prior cerebrovascular disease (CEVD) remains unclear. METHODS AND RESULTS: The SYNTAXES study assessed the vital status out to 10 year of patients with three-vessel disease and/or left main coronary artery disease enrolled in the SYNTAX trial. The relative efficacy of PCI vs. CABG in terms of 10 year all-cause death was assessed according to prior CEVD. The primary endpoint was 10 year all-cause death. The status of prior CEVD was available in 1791 (99.5%) patients, of whom 253 patients had prior CEVD. Patients with prior CEVD were older and had more comorbidities (medically treated diabetes, insulin-dependent diabetes, metabolic syndrome, peripheral vascular disease, chronic obstructive pulmonary disease, impaired renal function, and congestive heart failure), compared with those without prior CEVD. Prior CEVD was an independent predictor of 10 year all-cause death (adjusted HR: 1.35; 95% CI: 1.04–1.73; p = 0.021). Patients with prior CEVD had a significantly higher risk of 10 year all-cause death (41.1 vs. 24.1%; HR: 1.92; 95% CI: 1.54–2.40; p < 0.001). The risk of 10 year all-cause death was similar between patients receiving PCI or CABG irrespective of the presence of prior CEVD (p(-interaction) = 0.624). CONCLUSION: Prior CEVD was associated with a significantly increased risk of 10 year all-cause death which was similar in patients treated with PCI or CABG. These results do not support preferential referral for PCI rather than CABG in patients with prior CEVD. Trial registration: SYNTAX: ClinicalTrials.gov reference: NCT00114972. SYNTAX Extended Survival: ClinicalTrials.gov reference: NCT03417050. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00392-020-01802-x. Springer Berlin Heidelberg 2021-01-30 2021 /pmc/articles/PMC8484131/ /pubmed/33517534 http://dx.doi.org/10.1007/s00392-020-01802-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Wang, Rutao
Takahashi, Kuniaki
Garg, Scot
Thuijs, Daniel J. F. M.
Kappetein, Arie Pieter
Mack, Michael J.
Morice, Marie-Claude
Mohr, Friedrich-Wilhelm
Curzen, Nick
Davierwala, Piroze
Milojevic, Milan
van Geuns, Robert Jan
Head, Stuart J.
Onuma, Yoshinobu
Holmes, David R.
Serruys, Patrick W.
Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title_full Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title_fullStr Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title_full_unstemmed Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title_short Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study
title_sort ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the syntax extended survival study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484131/
https://www.ncbi.nlm.nih.gov/pubmed/33517534
http://dx.doi.org/10.1007/s00392-020-01802-x
work_keys_str_mv AT wangrutao tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT takahashikuniaki tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT gargscot tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT thuijsdanieljfm tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT kappeteinariepieter tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT mackmichaelj tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT moricemarieclaude tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT mohrfriedrichwilhelm tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT curzennick tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT davierwalapiroze tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT milojevicmilan tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT vangeunsrobertjan tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT headstuartj tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT onumayoshinobu tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT holmesdavidr tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy
AT serruyspatrickw tenyearallcausedeathfollowingpercutaneousorsurgicalrevascularizationinpatientswithpriorcerebrovasculardiseaseinsightsfromthesyntaxextendedsurvivalstudy